Human T-lymphotropic virus type I among blood donors from Guadeloupe: Donation, demographic, and biologic characteristics

Transfusion

Volumn 39, Issue 6, 1999, Pages 639-644

  Rouet, François ^a,b   Foucher, C ^a   Rabier, M ^a   Gawronski, I ^a   Taverne, D ^a   Chancerel, B ^a   Casman, O ^a   Strobel, M ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b Centre Hospitalier Universitaire Pointe a Pitre   (Guadeloupe)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN;

ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; DEMOGRAPHY; FEMALE; GUADELOUPE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; SEX DIFFERENCE; VIRUS TRANSMISSION;

BLOOD DONORS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MULTIVARIATE ANALYSIS; SEROEPIDEMIOLOGIC STUDIES; WEST INDIES;

EID: 0032994137     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39060639.x     Document Type: Article

References (24)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-9.
2. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, et al. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982;218:571-3.
3. Manns A, Wilks RJ, Murphy EL, et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 1992;51:886-91.
4. Blattner WA, Kalyanaraman VS, Robert-Guroff M, et al. The human type-C retrovirus, HTLV, in blacks from the Caribbean region and the relationship to adult T-cell leukemia/ lymphoma. Int J Cancer 1982;30:257-64.
5. Tajima K, Kamura S, Ito SI, et al. Epidemiological features of HTLV-I carriers and incidence of ATL in an ATL-endemic island: a report of the community-based cooperative study in Tsushima, Japan. Int J Cancer 1987;40:741-6.
6. Delaporte E, Buvé A, Nzila N, et al. HTLV-I infection among prostitutes and pregnant women in Kinshasa, Zaire: how important is high-risk sexual behavior? J Acquir Immune Defic Syndr 1995;8:511-5.
7. Bentrem DJ, McGovern EE, Hammarskjöld ML, Edlich RF. Human T-cell lymphotropic virus type-I (HTLV-I) retrovirus and human disease. Emerg Med 1994;12:825-32.
8. Gessain A, Gout O. Chronic myelopathy associated with human T lymphotropic virus type I (HTLV-I). Ann Intern Med 1992;117:933-46.
9. Massari V, Elghouzzi MH, Agis F, et al. Epidemiologic comparison of human T-lymphotropic virus type I-infected blood donors from endemic and nonendemic regions over a 3-year period. Transfusion 1994;34:198-201.
10. Figueroa JP. Heterosexual transmission of HTLV-I. Epidemiological aspects. West Indian Med J 1996;45:4-8.
11. Couroucé AM, Pillonel J, Lemaire JM, et al. Seroepidemiology of HTLV-I/II in universal screening of blood donations in France. AIDS 1993;7:841-7.
12. Acquired immuodeficiency syndrome (AIDS). Proposed WHO criteria for interpreting results from western blot assays for HIV-1, HIV-2 and HTLV-I/HTLV-II. Wkly Epidemiol Rec 1990;65:281-3.
13. Pillonel J, Couroucé AM, Elghouzzi MH, et al. Seroconversions to HTLV in blood donors (letter). Vox Sang 1996;70:47.
14. Montplaisir N, Valette I, Desaphy Y, et al. Blood transfusion and HTLV-I infection in Martinique. In: Roman GC, Vernant JC, Osame M. HTLV-I and the nervous system. New York: Liss, 1989;533-59.
15. De Thé G, Gessain A. Données séro-épidémiologiques des infections virales (HTLV-I et LAV/HTLV-III) dans la région Caraïbe et en Afrique intertropicale. Ann Pathol 1986;6:261-4.
16. Lee H, Anderson E, Allain JP, et al. HTLV-I infection in Brazil (letter). Blood 1989;73:1742.
17. Yamaguchi K, Nishimura Y, Kusumoto Y, et al. Declining trends of HTLV-I prevalence among blood donors in Kumamoto, Japan. J Acquir Immune Defic Syndr 1992;5:533-4.
18. Korelitz JJ, Williams AB, Bush MP, et al. Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study. Transfusion 1994;34:870-6.
19. Schreiber GB, Murphy EL, Horton JA, et al. Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and-II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr 1997;14:263-71.
20. Miller GJ, Pegram SM, Kirkwood BR, et al. Ethnic composition, age and sex, together with location and standard of housing as determinants of HTLV-I infection in an urban Trinidadian community. Int J Cancer 1986;38:801-8.
21. Mueller N, Tachibana N, Stuver SO, et al. Epidemiological perspectives of HTLV-I. In: Blattner WA, ed. Human retrovirology: HTLV. New York: Raven Press, 1990;281-93.
22. Murphy EL, Figueroa JP, Gibbs JP. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. Am J Epidemiol 1991;133:1114-24.
23. Ueda K, Kusuhara K, Tokugawa K, et al. Cohort effect on HTLV-I seroprevalence in southern Japan (letter). Lancet 1989;2:979.
24. Ferreira OC Jr, Vas RS, Carvalho MB, et al. Human T-cell lymphotropic virus infection among blood donors in South Florida. J Acquir Immune Defic Syndr 1991;4:89-96.